NBRx hasn't increased since October and then it was only short lived. Prior to that it was flat for 6 months. They put sales leaders in charge that did not even have good success as RSDs. What do you expect? Different results? They have run out of excuses. They hired nurses, IDs, more reps, RSDs, clinical people. They can't keep throwing good money after bad. It's only a matter of time before leadership pulls the plug. The drug is costing us way more than it will ever bring in, unfortunately.
Seroquel and Crestor competed in very different markets than today's. There has been so much talk and focus on making Brilinta a megabrand by Pascal and top leadership, that they may lose some face if they were to cut back significantly. It will need to be a decision made within the next year regardless of the OIG investigation. Regardless, it will need to be a business decision. NBRx and at least 90 day adherence rates really need to take off soon. They will have a tough time with the sales leaders they have in place. Some may have learned the market, but they lack the ability to motivate and lead/work through the many obstacles in today's complex environment.The question is could AZ save face by pulling Brilinta, or cutting the sales force back and allowing it to wither like Sular, Ropivacaine, or Accolate. At what point do you recognize failure, and what do you think would be the time line? It seems that three years would be a long time and two have already passed.
On the other side of the coin Seroquel and Crestor had slow starts but eventually ramped up. Does Brilinta still have a shot or is it down for the count?
All you need to do is line up all of the brand team and sales leaders, RSD and above and have everyone sit down who has never been involved in leading a successful product launch in any capacity. How many would remain standing? Nuff said.Seroquel and Crestor competed in very different markets than today's. There has been so much talk and focus on making Brilinta a megabrand by Pascal and top leadership, that they may lose some face if they were to cut back significantly. It will need to be a decision made within the next year regardless of the OIG investigation. Regardless, it will need to be a business decision. NBRx and at least 90 day adherence rates really need to take off soon. They will have a tough time with the sales leaders they have in place. Some may have learned the market, but they lack the ability to motivate and lead/work through the many obstacles in today's complex environment.
Why would all Pharma be doomed - unless not playing by the rules? Any suspect trials should not pass validation. These are chemicals, generally with both beneficial and harmful effects that people put into their bodies, in good faith that the compound has proven safety and efficacy in a well regulated and legitimate environment - as it should be.
Seroquel and Crestor competed in very different markets than today's. There has been so much talk and focus on making Brilinta a megabrand by Pascal and top leadership, that they may lose some face if they were to cut back significantly. It will need to be a decision made within the next year regardless of the OIG investigation. Regardless, it will need to be a business decision. NBRx and at least 90 day adherence rates really need to take off soon. They will have a tough time with the sales leaders they have in place. Some may have learned the market, but they lack the ability to motivate and lead/work through the many obstacles in today's complex environment.
Pascal/AZ will never voluntarily withdraw Brilinta from the market. Only the DOJ could force their hand, but i am sure they have already been paid off. Brilinta, in a few months will have been out 3 years. 3 years! How long are they going to continue dumping good money after bad???
AZ has been in a death spiral for several years and yet most people are just like sheep being led to the slaughter just living from day to day as if they don't have a problem in the world. I laugh when I hear some young newbie talking about how their DM is encouraging them to look for a promotion or developmental position. I compare it to competing for band director on the Titanic.This is the iceberg that is going to take AZ down and no spin can save it.
Soriet will not do the right thing and pull this drug off the market. This drug is tainted and no matter how many reps, nurses, rsd's dm's you throw at it it will never be a success. The right, ethical thing to do is pull it off the market at least show some ethics.
right to racism. you should be ashamed of your self. are you jelous because obama is bigger than you. guess you are a micro package boy.
